SCM
NUVB icon

Sio Capital Management’s Nuvation Bio NUVB Stock Holding History

Sio Capital Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-668,115
Closed -$1.78M – 60
2024
Q4 		$1.78M Hold
668,115
– – 0.5% 34
2024
Q3 		$1.53M Hold
668,115
– – 0.61% 25
2024
Q2 		$1.95M Sell
668,115
-668,116
-50% -$2.04M 0.53% 30
2024
Q1 		$4.86M Buy
+1,336,231
New +$2.57M 1.45% 25

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Sio Capital Management's NUVB Position: Q1 2025 in Review

Sio Capital Management sold out of Nuvation Bio (NUVB) in Q1 2025, closing a stake of 668,115 shares — an estimated $1.78M sold.

Sio Capital Management first reported a position in NUVB in Q1 2024 and held it in 4 quarters. The position peaked at $4.86M in Q1 2024. 161 funds tracked by Wall St. Rank hold NUVB as of Q1 2025.

  • Sio Capital Management reported no remaining Nuvation Bio position as of Q1 2025 after selling out during the quarter.
  • Sio Capital Management sold 668,115 Nuvation Bio shares in Q1 2025, an estimated $1.78M.
  • Sio Capital Management first reported a position in Nuvation Bio in Q1 2024 and held it in 4 quarters.
  • Sio Capital Management's Nuvation Bio position peaked at $4.86M in Q1 2024.
  • 161 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2025.

Based on Sio Capital Management's 13F filing for Q1 2025, filed 15 May 2025.